Lexeo Therapeutics Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

495.64M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	654.00K	-1.00M	-60.53%
Dec 31, 2021	1.66M	1.14M	219.59%
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Vanda Pharmaceuticals	216.11M
REGENXBIO	170.44M
Sutro Biopharma	102.48M
Assembly Biosciences	72.30M
XOMA Royalty	52.15M
Absci	2.80M
YD Bio	510.36K
vTv Therapeutics	17.00K

Revenue Rankings

LXEO News

14 days ago - Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights - GlobeNewsWire
6 weeks ago - Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference - GlobeNewsWire
2 months ago - Lexeo Therapeutics to Participate in Upcoming Investor Conferences in February - GlobeNewsWire
2 months ago - Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics - GlobeNewsWire
3 months ago - Lexeo Therapeutics Announces Positive Interim Phase I/II Data for LX2020 for the Treatment of PKP2-Associated Arrhythmogenic Cardiomyopathy - GlobeNewsWire
4 months ago - Lexeo Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
4 months ago - Lexeo Therapeutics to Host Virtual Key Opinion Leader Event at the 22nd Global Cardiovascular Clinical Trialists (CVCT) Forum - GlobeNewsWire
5 months ago - Lexeo Therapeutics Reports Third Quarter 2025 Financial Results and Operational Highlights - GlobeNewsWire

More News